$AFCG

AFC Gamma Q2 Earnings Call Highlights

AFC Gamma (NASDAQ:AFCG) reported Q2 earnings call highlights. It said originations may be lumpy, with about $80M in Q1 originations and less in Q2. As of June 30, fair value was $290M across 17 companies, weighted average yield 13.2%. Q2 investment income was $8.7M. NAV per share rose to $8.25; it repurchased ~839k shares at $3.29. DEBI liquidation term sheet targets $12.5M cash proceeds.

Original reporting
Published Aug 14, 2026, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 11:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AFC Gamma Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$AFCGNeutralMed
01

Why it matters

Traders can update expectations for near-term earnings power based on investment income trends, portfolio yield, and the timing of cash proceeds from legacy cannabis workouts.

02

Market read

Sequential NAV per share increased to $8.25 and liquidity remains available, but lower Q2 originations and ongoing legacy cannabis resolution risk keep the outlook balanced.

03

What to watch

Liquidity and co-investment relief may support future deployment, but the key swing factor is the pace and certainty of DEBI and other cannabis asset resolutions.

Relevance 6/10Novelty 6/10Timing: after-hours earnings call highlights, for positioning into the next trading session

Background

The piece summarizes AFC Gamma’s Q2 earnings call, covering portfolio composition, originations, legacy cannabis loan resolutions, and capital allocation.

Company-level read

Ticker impact

$AFCGNeutralMedium confidence
Context

AFC Gamma reported Q2 call details including $8.7M investment income, NAV per share rising to $8.25, and $2.8M share repurchases at $3.29.

Expected impact

Near-term trading likely muted unless investors focus on originations lumpy commentary and legacy cannabis resolution timelines.

Evidence & confidence

The article provides specific portfolio, income, NAV, and liquidity/repurchase figures, but no new guidance or surprise event beyond the quarter’s disclosed metrics.

Market effects

Highlights typical specialty finance REIT drivers: originations timing, portfolio yield, and legacy credit resolution risk.

Behavioral health platform commitment is Northeast-focused, but scale is small versus broader REIT market.

Limited, as disclosures are company-specific and not tied to global macro shocks.

Counterpoint

NAV rose, but originations were lower in Q2 and legacy cannabis remains concentrated in non-accrual assets, which can cap risk appetite.

Key entities

  • AFC Gamma, Inc.

    Specialty finance REIT focused on structured financing secured by real assets and contractual revenue streams.

  • DEBI (legacy cannabis loan)

    Receiver-led liquidation process with term sheet to sell additional assets for $12.5M cash proceeds, expected to close this year.

  • DMA (legacy cannabis loan)

    Receiver sold two of three dispensaries after regulatory approvals; one asset remains unresolved.

  • Justice Grown loan

    Matured May 1 and is in maturity default; AFC commenced Article 9 foreclosure actions and is pursuing remedies including guarantees.

Related articles

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 afcg-20260813xex991afcgear.htm EX-99.1 Document AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.

$TSSIMed

TSS Q2 Earnings Call Highlights

TSS (NASDAQ:TSSI) reported Q2 results on an earnings call. Systems integration remained the main growth driver, with gross profit up 11% to $8.0M and blended gross margin rising to 22.8%. Adjusted EBITDA increased 12% to $4.5M. TSS plans a ~$17M expansion for NVIDIA’s Vera Rubin platform, with incremental revenue expected to start in Q3 and mainly impact Q4.

$SLNHMed

Soluna Q2 Earnings Call Highlights

Soluna (NASDAQ: SLNH) reported Q2 net loss of $22.6 million, versus a $7.8 million loss in Q2 2025, driven by non-cash stock compensation, higher interest expense, and a loss on debt extinguishment. Adjusted EBITDA loss was $1.6 million. Revenue rose to $15.1 million. Soluna raised $159.4 million in the quarter and expects operating capacity to increase from 192 MW to 206 MW by summer end.

$ROCMed

Rank One Computing Q2 Earnings Call Highlights

Rank One Computing (NASDAQ:ROC) reported Q2 product revenue of $2.1M, down 26% YoY, mainly due to ROC Watch revenue falling 87% to $2.1M. Ex-ROC Watch, ROC SDK rose 84% to ~$1.6M, ROC ABIS rose 723% to ~$0.2M, and ROC Enroll rose 125% to ~$0.1M. Gross profit $4.6M, gross margin 90%. Net loss $0.8M. It agreed to acquire ZTC, expected to close by end of Q3.

$REKRMed

Rekor Systems Q2 Earnings Call Highlights

Rekor Systems (NASDAQ:REKR) reported Q2 cost reductions after headcount cuts, including a $2.8M non-cash lease liability remeasurement gain. Adjusted EBITDA loss narrowed 79% to about $1.2M. Cash was slightly above $10M, with operating cash burn at $2.4M. The company expects adjusted EBITDA profitability in 2H 2026 and is evaluating refinancing its Prime Revenue Sharing Notes.